Michael C. Carroll
Boston Children's Hospital · 397 works · 35,327 citations · h-index 97
Top works
- The structural basis of the multiple forms of human complement component C4
- A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2 and factor B
- Schizophrenia risk from complex variation of complement component 4
- A Hierarchical Role for Classical Pathway Complement Proteins in the Clearance of Apoptotic Cells in Vivo
- Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes.
- Mapping of steroid 21-hydroxylase genes adjacent to complement component C4 genes in HLA, the major histocompatibility complex in man.
- Arthritis Critically Dependent on Innate Immune System Players
- Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity.
- The complement system in regulation of adaptive immunity
- THE ROLE OF COMPLEMENT AND COMPLEMENT RECEPTORS IN INDUCTION AND REGULATION OF IMMUNITY
- Regulation of the B cell response to T-dependent antigens by classical pathway complement
- Molecular characterization of the HLA‐linked steroid 21‐hydroxylase B gene from an individual with congenital adrenal hyperplasia.
- A Critical Role of Natural Immunoglobulin M in Immediate Defense Against Systemic Bacterial Infection
- Bacteria activate sensory neurons that modulate pain and inflammation
- Deletion of complement C4 and steroid 21‐hydroxylase genes in the HLA class III region.
- Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement.
- Regulation of B Lymphocyte Responses to Foreign and Self-Antigens by the CD19/CD21 Complex
- Immunoglobulin G–mediated Inflammatory Responses Develop Normally in Complement-deficient Mice
- A Neurodegeneration-Specific Gene-Expression Signature of Acutely Isolated Microglia from an Amyotrophic Lateral Sclerosis Mouse Model
- B cell receptor signal strength determines B cell fate